ESBERITOX tabletta Ungārija - ungāru - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

esberitox tabletta

phytotec hungária bt. - baptisiae tinctoriae radix; lila coneflower gyökér; sápadt coneflower gyökér; thuja occidentalis -

Perfect Clean szilárd sampon mirtusz Ungārija - ungāru - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

perfect clean szilárd sampon mirtusz

urban s.r.l. - echinacea d4, phytolacca americana d5, acidum formicicum d4, arnica montana d6, atropa belladonna d6, bryonia cretica d8, calcium sulfuricum d12, silicea d10 - sampon - kutya

Calmacare belsőleges oldat Ungārija - ungāru - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

calmacare belsőleges oldat

boiron - chamomilla recutita for homeopathic preparations; phytolacca americana; rheum officinale -

Apexxnar Eiropas Savienība - ungāru - EMA (European Medicines Agency)

apexxnar

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumococcus fertőzések - a vakcinák - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. lásd a 4. 4 és 5. 1 a specifikus pneumococcus szerotípusok elleni védelemről. apexxnar should be used in accordance with official recommendations. .

Vaxneuvance Eiropas Savienība - ungāru - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumococcus fertőzések - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. lásd a 4. 4 és 5. 1 a specifikus pneumococcus szerotípusok elleni védelemről. the use of vaxneuvance should be in accordance with official recommendations.